Strontium ranelate
SIGMA/SML0596 - ≥98% (HPLC)
Synonym: 2-
CAS Number: 135459-87-9
Empirical Formula (Hill Notation): C12H6N2O8SSr2
Molecular Weight: 513.49
Linear Formula: C12H6N2O8SSr2
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C12H10N2O8S.2Sr/c13-2- |
| InChI key | XXUZFRDUEGQHOV-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | [Sr+2].[Sr+2].[s]1c(c(c(c |
| solubility | H2O: 1 mg/mL, clear (warmed) |
| storage temp. | −20°C |
| Biochem/physiol Actions: | Strontium ranelate is a dual action bone agent (DABA). It inhibits bone resorption and stimulates bone formation, inhibiting osteoclast differentiation while activating gene expression in osteoblasts. While its exact mechanism of action is unknown, one hypothesis is that both anabolic and anti-catabolic activities may involve antagonizing nuclear factor- |
| Biochem/physiol Actions: | Strontium ranelate is a dual action bone agent (DABA); inhibitor of bone resorption and stimulator of bone formation. |
| Features and Benefits: | This compound is featured on the Cytokine Receptors (Tumor Necrosis Receptor Family) page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Packaging: | 10, 50 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 + H312 + H332 |
| Precautionary statements | P280 - P301 + P312 + P330 - P302 + P352 + P312 - P304 + P340 + P312 |
| Hazard Codes | Xn |
| Risk Statements | 20/21/22 |
| Safety Statements | 36/37 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |


